Check out this Connecticut Public Radio piece highlighting LambdaVision’s International Space Station (ISS) National Lab investigation that recently launched on SpaceX’s 16th commercial resupply services mission. LambdaVision aims to use the microgravity environment of the ISS to improve the manufacturing process for the company’s protein-based retinal implant that is capable of restoring vision in patients with retinal degeneration.
Learn more about LambdaVision’s investigation in the ISS360 article “Setting Sights on Vision: Taking Flight to Improve Treatment for Retinal Degeneration” and in the video below.
